Skip to the content

We follow the authorship protocols of the International Committee of Medical Journal Editors

Browse our latest publications, posters, and presentations:

Publications

Liu J, Guo H, Rai P, Pinto L, Barron R. Medication persistence and risk of fracture among female Medicare beneficiaries with osteoporosis. Osteoporos Int. 2018;29:2409-2417.

Eidman KE, Wetmore JB. Managing hyperparathyroidism in chronic kidney disease: Role of etelcalcetide. Int J Nephrol Renovasc Dis. 2018;11:69-80.

Wetmore JB, Weinhandl ED, Zhou J, Gilbertson DT. Relative incidence of acute adverse events with ferumoxytol compared to other intravenous iron compounds: a matched cohort study. PLoS One. 2017;12:e0171098. doi:10.1371/journal.pone.0171098.

Block GA, Yusuf AA, Danese MD, Wirtz H, Hu Y, Do TP, Cooper K, Gilbertson DG, Bradbury BD, Collins AJ. Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. BMC Nephrol. 2016;17:166.

Wetmore JB. Parathyroidectomy: complex decisions about a complex procedure. Clin J Am Soc Nephrol. 2016;11:1133-1135.

Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ. Geographic variation of parathyroidectomy in hemodialysis patients: a retrospective cohort analysis. BMC Surg. 2016:16:77.

Wetmore JB, Liu J, Do TP, Low KA, Ishani A, Bradbury BD, Block GA, Collins AJ. Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy. Nephrol Dial Transplant. 2016;31:103-111.

Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury DB. Geovariation in fracture risk among patients receiving hemodialysis. Clin J Am Soc Nephrol. 2016;11:1413-1421.

Yusuf AA, Hu Y, Singh B, Menoyo JA, Wetmore JB. Serum potassium levels and mortality in hemodialysis patients. Am J Nephrol. 2016;44:179-186.

Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporosis. 2016;11:31.

Ishani A, Liu J, Wetmore JB, Lowe K, Do T, Bradbury BD, Block GA, Collins AJ. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol. 2015;10:90-97.

St. Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ. Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study. BMC Nephrol. 2015;16:41.

Arneson TJ, Li S, Liu J, Kilpatrick RD, Newsome BB, St. Peter WL. Trends in hip fracture rates in US hemodialysis patients from 1993 to 2010. Am J Kidney Dis. 2013;62:747-754.

Kilpatrick RD, Newsome BB, Zaun D, Liu J, Solid CA, Nieman K, St. Peter WL. Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients. Am J Nephrol. 2013;37:389-398.

Newsome BB, Kilpatrick RD, Liu J, Zaun D, Solid CA, Nieman K, St. Peter WL. Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients. Am J Nephrol. 2013;38:104-114.

Li S, Chen YW, Peng Y, Foley RN, St. Peter WL. Trends in parathyroidectomy rates in US hemodialysis patients from 1992-2007. Am J Kidney Dis. 2011;57:602-611.

Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, Liu J, St. Peter WL. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large hemodialysis population. Kidney Int. 2010;78:578-589.

St. Peter WL, Fan Q, Weinhandl ED, Liu J. Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: A secondary analysis using Centers for Medicare & Medicaid Services data. Clin J Am Soc Nephrol. 2009;4:1954-1961.

St. Peter WL, Li S, Liu J, Gilbertson DT, Arneson TJ, Collins AJ. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis. Pharmacotherapy. 2009;29:154-164.

St. Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA. Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004-2006. Clin J Am Soc Nephrol. 2009;4:354-360.

Publications

Herzog CA, Natwick, T, Li S, Charytan DM. Comparative utilization and temporal trends in cardiac stress testing in US patients with and without chronic kidney disease. Submitted to JACC: Cardiovasc Imaging. doi: 10.1016/j.jcmg.2018.04.012. [Epub ahead of print]

Gibbons RJ. Imperfect data can still provide important answers. JACC: Cardiovasc Imaging. doi: 10.1016/j.jcmg.2018.04.017. [Epub ahead of print]

Wetmore JB, Molony JT, Liu J, Peng Y, Herzog CA, Collins AJ, Gilbertson DT. Readmissions following a hospitalization for cardiovascular events in dialysis patients: a retrospective cohort studyJ Am Heart Assoc. 2018;7:e007231. DOI: 10.1161/JAHA.117.007231.

Wanner C, Herzog CA, Turakhia MP, Conference Steering Committee. Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018;94:231-234. doi: 10.1016/j.kint.2018.05.005.

Weir MA, Herzog CA. Beta blockers in patients with end-stage renal disease-evidence-based recommendations. Semin Dial. 2018;31:219-225. 

O’Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AY, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC. Cardiovascular outcomes reported in hemodialysis trials: consistent and important to patients? J Am Coll Cardiol. 2018;71:2802-2810.  

Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Amaoutakis GJ, Ding X, Engelman DT, Gasparovic H, Gasparovic V, Herzog CA, Kashani K, Katz N, Liu KD, Mehta RL, Ostermann M, Pannu N, Pickkers P, Price S, Ricci Z, Rich JB, Sajja LR, Weaver FA, Zarbock A, Ronco C, Kellum JA. Cardiac and vascular surgery-associated acute kidney injury: The 20th International Consensus Conference of the Acute Disease Quality Initiative (ADQI) Group. J Am Heart Assoc. 2018;7(11):e008834. doi: 10.1161/JAHA.118.008834.  

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJ, Pollock CA, Stevens PE, Kurella Tamura M, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): Conclusions from a KDIGO Controversies Conference. Kidney Int. 2018;93:1281-1292. 

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the Kidney Disease: Improving Global Outcomes 2017 clinical practice guideline update. Ann Intern Med. 2018;20;168:422-430. 

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018;39:2314-2325.  

Shroff GR, Li S, Herzog CA. Trends in discharge claims for acute myocardial infarction among patients on dialysisJ Am Soc Nephrol. 2017;28:1379-1383.

Shroff GR, Solid CA, Bloomgarden Z, Halperin JL, Herzog CA. Temporal trends in ischemic stroke and anticoagulation therapy for nonvalvular atrial fibrillation: impact of diabetesJ Diabetes. 2017;9:115-122.

Bansal VK, Herzog CA, Sarnak MJ, Choi MJ, Mehta R, Jaar BG, Rocco MV, Kramer H. Oral anticoagulants to prevent stroke in nonvalvular atrial fibrillation in patients with CKD stage 5D: An NKF-KDOQI Controversies Report. Am J Kidney Dis. 2017;70:859-868. 

Asinger RW, Shroff GR, Simegn MA, Herzog CA. Anticoagulation for non-valvular atrial fibrillation: influence of epidemiologic and clinical trends on risk stratification and net clinical benefit. Circ Cardiovasc Qual Outcomes. 2017;10(9). pii: e003669. doi: 10.1161/CIRCOUTCOMES.117.003669.

Bovitz T, Gilbertson DT, Herzog CA. Administrative data and the philosopher’s stone: turning heart failure claims data into quantitative assessment of left ventricular ejection fractionAm J Med. 2016;129:223-225.

Shroff GR, Herzog CA. Coronary revascularization in patients with CKD stage 5D: pragmatic considerationsJ Am Soc Nephrol. 2016;27:3521-3529.

Sandoval Y, Herzog CA, Love SA, Cao J, Hu Y, Wu AH, Gilbertson D, Brunelli SM, Young A, Ler R, Apple FS. Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients. Clin Chem. 2016;62:631-638.

Herzog CA. Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Verdict 2. Editorial. Clin J Am Soc Nephrol. 2016;11:2095-2096. 

Shroff GR, Solid CA, Herzog CA. Impact of acute coronary syndromes on survival of dialysis patients following surgical or percutaneous coronary revascularization in the United States. Eur Heart J Acute Cardiovasc Care. 2016;5:205-213.  

Shroff GR, Herzog CA. Beta-blockers in dialysis patients: a cardiology perspectiveJ Am Soc Nephrol. 2015;26:774-776.

Shroff GR, Solid CA, Herzog CA. Medicare claims for myocardial infarction as primary vs. secondary diagnosisInt J Cardiol. 2015;182:412-413.

Shroff GR, Li S, Herzog CA. Trends in mortality following acute myocardial infarction among dialysis patients in the United States over 15 years. J Am Heart Assoc. 2015;4:e002460 doi: 10.1161/JAHA.115.002460.

Herzog CA, Shroff GR. Atherosclerotic versus non-atherosclerotic evaluation: the yin and yang of cardiovascular imaging in advanced chronic kidney diseaseJACC Cardiovasc Imaging. 2014;7:729-732.

Kalra A, Shroff GR, Erlien D, Gilbertson DT, Herzog CA. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts. Research Letter JACC Cardiovasc Imaging. 2014;7:206-207.

Kalra A, Shroff GR, Herzog CA. Safety of ultrasound contrast agents in patients with intracardiac shuntsJ Am Soc Echocardiogr. 2014;27:1359.

Shroff GR, Heubner BM, Herzog CA. Incidence of acute coronary syndrome in the general Medicare population, 1992-2009: A real-world perspective. JAMA Int Med. 2014;174:1689-1690.

Shroff GR, Solid CA, Herzog CA. Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010J Am Heart Assoc. 2014;3:e000756 doi:10.1161/JAHA.113.000756.

Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drueke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman M, Abdalla S, Chertow GM, Herzog CA, and the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: The The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. J Am Heart Assoc. 2014;3:e001363. doi: 10.1161/JAHA.114.001363 

Chawla LS, Herzog CA, Costanzo MR, Tumlin J, Kellum JA, McCullough PA, Ronco C, for the ADQI XI Workgroup. Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the Acute Dialysis Quality Initiative (ADQI) XI Workgroup. J Am Coll Cardiol. 2014;63:1246-1252.

Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA. Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med. 2014;29(Suppl 3):S724-731. doi: 10.1007/s11606-014-2910-1.

Shroff GR, Herzog CA. Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doingKidney Int. 2013;84: 230-233.

Shroff GR, Solid CA, Herzog CA. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013;127:1861-1869.

Shroff GR, Herzog CA. Echocardiography: providing additional insight into cardiovascular structural and functional abnormalities in advanced chronic kidney disease. Clin J Am Soc Nephrol. 2013;8:339-341.

Shroff  GR, Solid CA, Herzog CA. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: A 15-year perspective, 1992-2007JAMA Int Med. 2013;173;159-160.

The EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367:2482-2494.

Charytan DM, Li S, Liu J, Herzog CA. Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. 2012;126(11 Suppl 1):S164–S169.

Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: Clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. Am Heart J. 2012;163:399-406.

Brenden CK, Eckman PM, Bruce-Fane L, Erlien D, Herzog CH. Atropine augmentation of exercise stress echocardiographyEchocardiography. 2011;28:1109-1112.

Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach S, Pun PH, Ritz E. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80:572-586. 

Sharma A, Gilbertson DT, Herzog CA. Survival of kidney transplantation patients in the United States after cardiac valve replacement. 2010;121:2733-2739. 

Shroff GR, Li S, Herzog CA. Survival of patients on dialysis having off-pump versus on-pump coronary artery bypass surgery in the United States. J Thorac Cardiovasc Surg. 2010;139:1333-1338. 

Herzog CA. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. 2008;299:2023-2025. 

Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation. 2007;116:1465-1472.

Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA. Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002). 2006;37:1969-1974.

Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005;68:818-825.

Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S and Herzog CA. Angiotension-converting enzyme inhibitor as a risk for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391-399.

Herzog CA, Ma JZ and Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedure. Circulation. 2004;109:2866-2871.

Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207-2211.

Chavers B, Li S, Collins A, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002;62:648-653.

Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-2945.

Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients in the United States with prosthetic heart valves:  Should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002;105:1336-1341.

Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int. 1999;56:324-332. 

Publications

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM. Impact of renal disease on patients with hepatitis C: a retrospective analysis of disease burden, clinical outcomes, and health care utilization and cost. Nephron. 2017;136:54-61.

Israni AK, Xiong H, Liu J, Salkowski N, Trotter JF, Snyder JJ, Kasiske BL. Predicting end-stage renal disease after liver transplantAm J Transplant. 2013;13:1782-1792.

Posters & Presentations

Prevalence of Hepatitis C Virus (HCV) Infection and Associated Comorbidities in the 2008-2014 US Hemodialysis Population. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Increasing Healthcare Resource Utilization (HCRU) and Costs Associated with Advanced Liver Disease – a Multivariate Analyses of Real-World Medicare Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients. Gordon S, Fraysse J, Li S, Wong R. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Increased Risk of Mortality in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients: Real-World Analysis of 2007-2015 Medicare Data. Loomba R, Fraysse J, Li S, Harrison S. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2018.

Substantial Healthcare Utilization (HCU) and Costs among Nonalcoholic Steatohepatitis (NASH) Patients with Comorbid Diabetes Mellitus (DM): Real-World Analysis of 2007-2015 US Medicare Data. Gordon, S. Li, Y. Peng, X. Wang X, R. Wong. Presented at the European Association for the Study of the Liver, International Liver Conference, 2018.

Health Care Costs are Double for Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Compensated Cirrhosis (CC) Who Progress to End-Stage Liver Disease (ESLD). Loomba, S. Li, Y. Peng, X. Wang, S. Harrison. Presented at the European Association for the Study of the Liver, International Liver Conference, 2018.

Sofosbuvir-Based Therapy is Associated with Higher Incidence of De-Registration for Clinical Improvement in Hepatitis C Patients Awaiting Liver Transplantation: An Analysis of SRTR-Symphony Database. Ray Kim, Beth Dellay, Jeffrey H. Wang, Yi Peng, Anne Sexter, Ajay Israni. Presented at the American Association for the Study of Liver Diseases, Liver Meeting, 2017.

Posters & Presentations

TNF Inhibitors: Prevalence of Use and Predictors of Treatment Non-Persistence in the 2011-2016 Medicare Population. Nicholas S. Roetker, Yi Peng, Kimberly M. Nieman, Suying Li, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018. 

All-Cause Mortality, Hospitalization, and Systemic Lupus Erythematosus (SLE)-Related Complications in 2011-2015 Medicare Beneficiaries with SLE. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018.

Prevalence of Systemic Lupus Erythematosus (SLE) and Associated Comorbidity in the 2011-2015 Medicare Population. Suying Li, Tingting Gong, Yi Peng, Kimberly M. Nieman, and David T. Gilbertson. Presented at the American College of Rheumatology, 2018.

Prevalence of Rheumatoid Arthritis and Associated Comorbidities in the 2011-2015 Medicare Population. Suying Li, Julia T. Molony, Yi Peng, Kimberly M. Nieman, David T. Gilbertson. Presented at the American College of Rheumatology, 2017.

Publications

Wetmore JB, Li S, Yan H, Xu H, Peng Y, Sinsakul MV, Liu J, Gilbertson DT. Predialysis anemia management and outcomes following dialysis initiation: a retrospective cohort study. PLOS One. 2018;13(9):e0203767.

Eidman KE, Wetmore JB. Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? Semin Dial. 2018;31:440-444.

Wetmore JB, Yan H, Hu Y, Gilbertson DT, Liu J. Factors associated with withdrawal from maintenance dialysis: a case-control analysis. Am J Kidney Dis. 2018;71:831-841.

Collins AC, Kliger AS. Urgent: stop preventable infections nowClin J Am Soc Nephrol. 2018;13:663-665.

St Peter WL, Guo H, Kabadi S, Gilbertson DT, Peng Y, Pendergraft T, Li S. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the USBMC Nephrol. 2018;19:67.

Wetmore JB, Li, S, Molony JT, Guo H, Herzog CA, Gilbertson DT, Peng Y, Collins AJ. Insights from the 2016 Peer Kidney Care Initiative Report: Still a ways to go to improve care for dialysis patients. Am J Kidney Dis. 2018;71:123-132.

Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study. Clin Nephrol. 2017;88:254-263.

Wang CJ, Wetmore JB, Israni AK. Old versus new: progress in reaching the goals of the new kidney allocation system. Hum Immunol. 2017;78:9-15.

Solid CA, Peter SA, Natwick T, Guo H, Collins AJ, Arduino JM. Impact of renal disease on patients with hepatitis C: a retrospective analysis of disease burden, clinical outcomes, and health care utilization and cost. Nephron. 2017;136:54-61.

Wetmore JB, Liu J, Li S, Hu Y, Peng Y, Gilbertson DT, Collins AJ. The Heathy People 2020 objectives for kidney disease: how far have we come, and where do we need to go? Clin J Am Soc Nephrol. 2017;12:200-209.

Chertow GM, Liu J, Monda K, Gilbertson DT, Brookhart MA, Beaubrun A, Winkelmayer WC, Pollack A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ. Epoetin alfa and outcomes in dialysis patients amid regulatory and payment reform. J Am Soc Nephrol. 2016;27:3129-3138.

Liu J, Krishnan M, Zhou J, Nieman KM, Peng Y, Gilbertson DT. Data completeness as an unmeasured confounder in dialysis facility performance comparison with 1-year follow-up. Clin Nephrol. 2016;86:262-269.

Molony JT, Monda KL, Li S, Beaubrun A, Gilbertson DT, Bradbury BD, Collins AJ. Effects of epoetin alfa titration practices, implemented after changes to product labeling, on hemoglobin levels, transfusion use, and hospitalization rates. Am J Kidney Dis. 2016;68:266-276.

Weinhandl ED, Gilbertson DT, Collins AJ. Mortality, hospitalization, and technique failure in daily home hemodialysis and matched peritoneal dialysis patients: A matched cohort study. Am J Kidney Dis. 2016;67:98-110.

Wetmore JB, Collins AJ. Global challenges posed by the growth of end-stage renal disease. Renal Replac Ther. 2016;2:15. DOI 10.1186/s41100-016-0021-7.

Wetmore JB, Gilbertson DT, Collins AJ. Shaping public health initiatives in kidney diseases: the PEER Kidney Care Initiative. Blood Purif. 2016;41:151-158.

Wetmore JB, Gilbertson DT, Liu J, Collins AJ. Improving outcomes in patients receiving dialysis: the Peer Kidney Care Initiative. Clin J Am Soc Nephrol. 2016;11:1297-1304.

Wetmore JB, Guo H, Gilbertson DT, Collins AJ. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney Int. 2016;90:853-860.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT. Patient characteristics, disease burden, and medication use in stage 4-5 chronic kidney disease patients. Clin Nephrol. 2016;85:101-111.

Wetmore JB, Tzivelekis S, Collins AJ, Solid CA. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care. BMC Nephrol. 2016;17:53. DOI 10.1186/s12882-016-0267-x.

Gilbertson DT, Wetmore JB. Infections requiring hospitalization in hemodialysis patients. Clin J Am Soc Nephrol. 2015;10:2101-2103.

Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson Jr E. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal System Data. Am J Kidney Dis. 2015;66:802-812.

St. Peter WL. Management of polypharmacy in dialysis patients. Sem Dial. 2015;28:427-432.

Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis. 2015;65:98-108.

Wetmore JB, Collins AJ. Meeting the world’s need for maintenance dialysis. J Am Soc Nephrol. 2015;26:2601-2603.

Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol. 2015;41:354-361.

Collins AJ, Molony J, Li S, Monda KL, Gilbertson DT, Bradbury BD. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. Am J Kidney Dis. 2014;63:997-1006.

Foley RN, Solid CA, Lamb K. Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009. Hemodial Int. 2014;18:24-31.

Hakim RM, Collins AJ. Reducing avoidable re-hospitalization in ESRD: a shared accountability. J Am Soc Nephrol. 2014;25:1891-1893.

Ishani A, Gilbertson DT, Kim D, Bradbury BD, Collins AJ. Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula. Am J Nephrol. 2014;39:238-247.

Liu J, Li S, Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices. Am J Kidney Dis. 2014;64:608-615.

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Hemodialysis patient outcomes: provider characteristics. Am J Nephrol. 2014;39:367-375.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Provider and care characteristics associated with timing of dialysis initiation. Clin J Am Soc Nephrol. 2014;9:310-317.

Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL. Am J Kidney Dis. 2013;62:919-928.

Gilbertson DT, Peng Y, Arneson TJ, Dunning S, Collins AJ. Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics. BMC Nephrol. 2013;14:44.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Predictors of provider-patient visit frequency during hemodialysis. Am J Nephrol. 2013;38:91-98.

St. Peter WL, Odum LE, Whaley-Connell AT. To RAS or not to RAS? The evidence for and caution with renin-angiotensin system inhibition in patients with diabetic kidney disease. Pharmacotherapy. 2013;33:496-514.

St. Peter WL, Shafi T, Sozio SM, Luly J, Bandeen-Roche K, Ephraim PL, Michels W, Crews DC, Miskulin DC, Jaar BG, Wu A, Boulware LE, for the DEcIDE Network. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013;14:249.

St. Peter WL, Wazny LR, Patel U. New models of CKD care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens 2013;22:656-662.

St. Peter WL, Weinhandl ED, Flessner MF. Sitagliptin—Another option for managing type 2 diabetes in dialysis patients? Am J Kidney Dis. 2013;61:532-535.

Weinhandl ED, Arneson TJ, St. Peter WL. Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report. Am J Kidney Dis. 2013;62:557-567.

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A. Association of provider-patient visit frequency and patient outcomes on hemodialysis. J Am Soc Nephrol. 2012;23:1560-1567.

Weinhandl ED, Liu J, Gilbertson DT, Arneson TJ, Collins AJ. Relative mortality in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23:895-904.

Gilbertson DT, Guo H, Arneson TJ, Collins AJ. Pneumococcal vaccination and pneumonia-related outcomes in hemodialysis patients. Nephrol Dial Transplant. 2011;26:2934-2939.

Kalirao P, Pederson SL, Robert N. Foley, Kolste A, Tupper DE, Zaun D, Vanessa Buot, Murray AM. Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis. 2011;57:612-620.

Murray AM, Barzilay JI, Lovato JF, Williamson JD, Miller ME, Marcovina S, Launer LJ, for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Investigators. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care. 2011;34:1827-1832.

Weinhandl ED, Gilbertson DT, Collins AJ. Association of mean weekly epoetin alfa dose with mortality risk in a retrospective study of Medicare patients. Am J Nephrol. 2011;34:298-308.

Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis. 2011;57:255-265.

Arneson TJ, Liu J, Qui Y, Gilbertson DT, Foley RN, Collins AJ. Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol. 2010;5:1054-1063.

Foley RN, Roberts TL, Liu J, Gilbertson DT, Arneson TJ, Dunning S, Collins AJ. Mortality from cancer among US hemodialysis patients, 1995-2005. Am J Nephrol. 2010;31:518-526.

Mau LW, Liu J, Qui Y, Guo H, Ishani A, Arneson TJ, Gilbertson DT, Dunning SC, Collins AJ. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis. 2010;55:549-557.

Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010;21:499-506.

Arneson TJ, Zaun D, Peng Y, Solid CA, Dunning S, Gilbertson DT. Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population. Nephrol Dial Transplant. 2009; 24:1378-1383.

Collins AJ, Guo H, Gilbertson DT, Bradbury BD. Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia. Nephron Clin Pract. 2009;111:c141-c148.

Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ. Hemoglobin level variability: anemia management among variability groups. Am J Nephrol. 2009;30:491-498.

Ibrahim HN, Foley RN, Zhang R, Gilbertson David T, Collins AJ. Parenteral iron use: Possible contribution to exceeding target hemoglobin in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:623-629.

Ibrahim HN, Ishani A, Guo H, Gilbertson DT. Blood transfusion use in nondialysis-dependent chronic kidney disease patients aged 65 years and older. Nephrol Dial Transplant. 2009;24:3138-3143.

Ishani A, Guo H, Arneson TJ, Gilbertson DT, Mau LW, Li S, Dunning S, Collins AJ. Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol. 2009;20:1607-1613.

Liu J, Guo H, Gilbertson DT, Foley RN, Collins AJ. Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis. Ther and Clin Risk Manage. 2009;5:319-330.

Posters & Presentations

Economic Burden of Anemia-Related Transfusions in Medicare Dialysis Patients. David T. Gilbertson, Suying Li, Tara Matsuda, Yi Peng, Vasily Belozeroff, Nisha Bhatt, James B. Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2018.

Trends in Hospitalization, Emergency Dept. Encounters, and Observation Stays in Prevalent Hemodialysis Patients. David T. Gilbertson, Peer Kidney Care Initiative Investigators. Presented at the National Kidney Foundation Spring Clinical Meeting, 2017.  

Patterns of Anemia Management in the Predialysis Period. James B. Wetmore, Heng Yan, David T. Gilbertson, Hairong Xu, Marvin V. Sinsakul, Yi Peng, Jiannong Liu, Suying Li. Presented at the American Society of Nephrology Annual Meeting, 2017.

Hospital Transfusion Use and Infection-Related Re-Hospitalization among Patients on Dialysis. David T. Gilbertson, Suying Li, Jiannong Liu, James B. Wetmore, Anne Beaubrun, Paul Dluzniewski, Xinyue Wang, Brian Bradbury. Presented at the National Kidney Foundation Spring Clinical Meeting, 2016. 

Cardiac Stress Testing in U.S. Patients with Chronic Kidney Disease: Is the Epoch of Nihilism and Renalism Ancient History? Charles A. Herzog, Tanya Natwick, Shuling Li, David M. Charytan. Presented at the American Society of Nephrology Annual Meeting, 2016.

High Dose Erythropoiesis-Stimulating Agent Is Associated with Increased Healthcare Resource Utilization and Risk of Adverse Events in Non-Dialysis-Dependent Chronic Kidney Disease Patients. David T. Gilbertson, Suying Li, Yi Peng, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, and Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2016.

Unexpected Medical Consequences of Revised ESA Label in Non-Dialysis Dialysis-Dependent Chronic Kidney Disease Patients with Anemia. Suying Li, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, Yi Peng, Wendy St. Peter, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2016.

Anemia Prevalence and Treatment in Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Suying Li. Presented at the American Society of Nephrology Annual Meeting, 2016.

Anemia is Associated with Higher Healthcare Utilization and Costs in Non-Dialysis-Dependent Chronic Kidney Disease Patients. Suying Li, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Wendy L. St. Peter. Presented at the Academy of Managed Care Pharmacy, 2016.

Anemia Prevalence and Treatment Patterns in Non-Dialysis-Dependent Chronic Kidney Disease Patients Before and After Revised FDA Label and Anemia Guidelines for Erythropoiesis-Stimulating Agents. Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, Sean Zhao, David T. Gilbertson, Louise Sargent Heuer, Yi Peng, Trudy Pendergraft, Suying Li. Presented at the Academy of Managed Care Pharmacy, 2016.  

Anemia Prevalence and Treatment Rates in Stage 3-5 Non-Dialysis-Dependent Chronic Kidney Disease Patients. David T. Gilbertson, Suying Li, Yi Peng, Haifeng Guo, Shaum Kabadi, Sean Zhao, Trudy Pendergraft, Louise Sargent Heuer, Wendy L. St. Peter. Presented at the Academy of Managed Care Pharmacy, 2016.

Temporal Trends in Myocardial Infarction Incidence and 30-Day Mortality in U.S. Dialysis Patients. Charles A. Herzog, Keri L. Monda, Anne C. Beaubrun, Wolfgang C. Winkelmayer, Til Sturmer, Allan J. Collins, Akhtar Ashfaq, Kenneth J. Rothman, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2015.

Influenza and Outcomes in ESRD Patients. David T. Gilbertson, Anne C. Beaubrun, Kenneth J. Rothman, Jiannong Liu, Brian D. Bradbury, Akhtar Ashfaq, Charles A. Herzog, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2015.

Variability in Hemoglobin (Hb) Levels in Hemodialysis (HD) Patients in the Current Era. Dave Gilbertson, Yan Hu, Yi Peng, Sarb Shergill, Bradley Maroni. Presented at the American Society of Nephrology Annual Meeting, 2015.

Comorbidity Data Source may Impact SMR/SHR Calculation. Jiannong Liu, Mahesh Krishnan, Jincheng Zhou, Kimberly Nieman, Yi Peng, David Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2015.

Trends in 30-Day Readmission Rates in Dialysis Patients during an Era of Medicare Payment Policy Changes, 1996-2012. Suying Li, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015.

Increasing Prevalence of Withdrawal from Dialysis: Trends from 2004-2011. James Wetmore, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015.

Trends in Incident ESRD Counts: Regional Variation in Initiating Dialysis in Freestanding Facilities. Dave Gilbertson, Peer CMO group. Presented at the American Society of Nephrology Annual Meeting, 2015. 

Frequency of Hyperkalemia Events in Dialysis Patients in a Large Dialysis Organization. Akeem Yusuf, Yan Hu, Bhupinder Singh, Alex Yang, James Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2015.

Serum Potassium Levels and Mortality in Hemodialysis Patients. Akeem Yusuf, Yan Hu, Bhupinder Singh, Jose Menoyo, Alex Yang, James Wetmore. Presented at the American Society of Nephrology Annual Meeting, 2015.

30-Day Readmission Rates after Heart Failure and Hypertensive Disease Discharges in Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Lower Risk of Early Death in Incident Dialysis Patients on Daily Home versus In-center Hemodialysis. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Insufficient Risk Adjustment of Quality Metrics for a Niche Dialysis Provider. Eric Weinhandl, Steve Bucher. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Facility-Level CKD-MBD Composite Score and Risk of Adverse Clinical Outcomes among Patients on Hemodialysis. David Gilbertson, Yan Hu, Heidi Wirtz, Akeem Yusuf, Thy Do, Brian Bradbury, Kerry Cooper, Mark Danese, Allan Collins, Geoff Block. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Comorbidity Burden and Medication Use in Stage 4-5 CKD Patients. David T. Gilbertson, Yi Peng, Scott Jackson, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Clinical Consequences Following Parathyroidectomy in a Nationwide Cohort of Patients on Hemodialysis. Areef Ishani, Jiannong Liu, James B. Wetmore, Kim Lowe, Thy Do, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Patterns of Anemia Management in Patients Undergoing Peritoneal Dialysis. Yi Peng, Allyson Kats, David T. Gilbertson, Deborah Kim, Keri L. Monda, James B. Wetmore, Brian D. Bradbury, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Characteristics Associated with Parathyroidectomy in Medicare Hemodialysis Patients. James B. Wetmore, Jiannong Liu, Kimberly A. Lowe, Areef Ishani, Thy P. Do, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014.

Prevalence of Glomerulonephritis in the U.S: Insights from a Large Administrative Dataset. James B. Wetmore, Haifeng Guo, David T. Gilbertson. Presented at the National Kidney Foundation Spring Clinical Meeting, 2014. 

Trends in Anemia Management in US Patients on Dialysis, 2005-2011. David T. Gilbertson, Anne C. Beaubrun, Jiannong Liu, Akhtar Ashfaq, Wolfgang C. Winkelmayer, Glenn M. Chertow, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Facility EPO Titration Practices, Hemoglobin Levels, and Transfusion Use. Julia T. Molony, Keri L. Monda, Suying Li, Anne Beaubrun, David T. Gilbertson, Brian D. Bradbury, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Geographic Variation in Fracture Incidence in US Patients Receiving Hemodialysis. James B. Wetmore, Jiannong Liu, Heidi S. Wirtz, Thy P. Do, David T. Gilbertson, Brian D. Bradbury, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Evaluating Observed vs. Expected Mortality Rates in US Dialysis Patients Amid Secular Declines. Jiannong Liu, Keri L. Monda, Charles A. Herzog, M. Alan Brookhart, Til Stürmer, Brian D. Bradbury, Kenneth J. Rothman, Glenn M. Chertow. Presented at the American Society of Nephrology Annual Meeting, 2014.

Changes in PTH, Calcium, and Phosphorous Levels after Parathyroidectomy in Patients on Hemodialysis. James B. Wetmore, Jiannong Liu, Thy P. Do, Kimberly A. Lowe, Areef Ishani, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Prevalence of Glomerulonephritis in the U.S. Medicare Population. James B. Wetmore, Haifeng Guo, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2014.

Transfusion Events in Hemodialysis Patients by Hemoglobin Level, ESA Users vs. Non-ESA Users. Allan J. Collins, Tom Matlon, Yi Peng, David T. Gilbertson. Presented at the American Society of Nephrology Annual Meeting, 2014.

Lower Risks of Death and On-Treatment Hospitalization in DaVita Rx Members versus Matched Controls. Eric D. Weinhandl, Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2014.

Increases in Medication Use after New Membership in DaVita Rx. Eric D. Weinhandl, Wendy L. St. Peter. Presented at the American Society of Nephrology Annual Meeting, 2014.

Lower Risk of Technique Failure in Daily Home Hemodialysis versus Peritoneal Dialysis Patients. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Lower Risk of Hospitalization in Daily Home Hemodialysis versus Peritoneal Dialysis Patients. Eric D. Weinhandl, Kimberly M. Nieman, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014. 

Differences in Medication Use among Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Dialysis Facility-Level Transfusion Rates Can Be Unreliable Due to Variability in Hospital-Level Billing Patterns for Blood. Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins. Presented at the American Society of Nephrology Annual Meeting, 2014.

Publications

Li S, Liu J, Virnig BA, Collins AJ. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early stage breast cancer. Breast Cancer Res Treat. 2017;161:515-524.

Sosa R, Li S, Molony JT, Liu J, Stryker S, Collins AJ. Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database. Support Care Cancer. 2017;25:3123-3132.

Yusuf AA, Natwick T, Werther W, Felici D, Mahue M, Bridges K, Peng Y. A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma. Curr Med Res Opin. 2016;32:1989-1996.

Arneson TJ, Li S, Gilbertson DT, Bridges KR, Acquavella JF, Collins AJ. Impact of Centers for Medicare & Medicaid Services National Coverage Determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patients. Pharmacoepidemiol Drug Saf. 2012;21:857-864.

Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia V, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ. Estimated number of prevalent cases of diagnosed bone metastases in the US adult population. Clin Epidemiol. 2012;4:87-93.

Posters & Presentations

Trends in Neutropenia-Related Hospitalization in Older Patients With Non-Hodgkin Lymphoma Receiving Myelosuppressive Chemotherapy in the United States: 1995–2015. Shuling Li, Jiannong Liu, Haifeng Guo, Prasad L. Gawade, Christopher Kim, Mark E. Bensink, and David Chandler. Presented at the American Society of Hematology Annual Meeting, 2018.

Variations in Hospitalization and Emergency Department/Observation Stays Using the Oncology Care Model Methodology in Medicare Data. Shuling Li, Yi Peng, Suying Li, Leon Raskin, Michael A. Kelsh, Rebecca Zaha, Prasad L. Gawade, David Henry. Presented at the American Society of Clinical Oncology Quality Care Symposium, 2018.

Hospitalization and Hospital Discharge Destinations After Chemotherapy: Using the Oncology Care Model Methodology in 2012–2015 Medicare Data. Yi Peng, Jiannong Liu, Shuling Li, Leon Raskin, Michael A. Kelsh, Rebecca Zaha, Rohini K. Hernandez, David Henry, Gary H. Lyman. Presented at the American Society of Clinical Oncology Quality Care Symposium, 2018.

Rituximab Use in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Julia T. Molony, Anne Sexter, Karynsa Cetin, Ivy Altomare, Jeffery Wasser. Presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2018.

Mortality by Frailty Status as Defined by a Claims-Based Disability Status in Elderly Patients with Newly Diagnosed Multiple Myeloma in the United States. Shuling Li, Tanya Natwick, Jiannong Liu, Vicki A. Morrison, Sarah Vidito, Winifred Werther, Khalid Mezzi, Akeem Yusuf, Jatin Shah, Saad Usmani. Presented at the International Myeloma Workshop, 2017. 

Transitions Across Different Lines of Therapy in Medicare-Enrolled Patient Populations with Multiple Myeloma. Akeem A. Yusuf, Tanya Natwick, Diana Felici, Winifred Werther. Presented at the American Society of Clinical Oncology Annual Meeting, 2016.

Treatment Regimens and Duration of Lines of Therapy in Medicare-Enrolled Patients with Multiple Myeloma. Akeem A. Yusuf, Tanya Natwick, Diana Felici, Winifred Werther. Presented at the American Society of Clinical Oncology Annual Meeting, 2016.

Treatment Sequencing Patterns in Medicare-Enrolled Patients with Multiple Myeloma. Shuling Li, Tanya Natwick, Akeem Yusuf, Sarah Vidito, Khalid Mezzi, Winifred Werther. Presented at the American Society of Hematology Annual Meeting, 2016.

Mortality among Elderly Patients Newly Diagnosed with Acute Lymphoblastic Leukemia (ALL), using 100% Medicare ALL Data. Shuling Li, Julia T. Molony, Victoria M. Chia, Aaron J. Katz. Presented at the American Society of Clinical Oncology Annual Meeting, 2016. 

Patient Characteristics and Treatment Patterns in Elderly Patients Newly Diagnosed with ALL using 100% Medicare ALL Data. Shuling Li, Julia T. Molony, Victoria M. Chia, Aaron J. Katz. Presented at the American Society of Hematology Annual Meeting, 2016. 

Association between Adjuvant Chemotherapy and Risk of Acute Kidney Injury in Elderly Women Diagnosed with Early Stage Breast Cancer. Shuling Li, Jiannong Liu, Beth A. Virnig, Allan J. Collins. Presented at the San Antonio Breast Cancer Symposium, 2014.

Association between Adjuvant Chemotherapy and Risk of Chronic Kidney Disease in Elderly Women Diagnosed with Early Stage Breast Cancer. Shuling Li, Jiannong Liu, Beth A. Virnig, Allan J. Collins. Presented at the San Antonio Breast Cancer Symposium, 2014.

Co-Morbidities in Elderly Breast Cancer and Lung Cancer Patients Who Receive Chemotherapy of NCCN Defined Intermediate Risk of Febrile Neutropenia. John H. Page, Shuling Li, Julia Molony, Romina Sosa, Richard Barron, Phuong Khanh Morrow, Scott Stryker, Jiannong Liu, Allan J. Collins, John Acquavella. Oral presentation at the Multinational Association of Supportive Care in Cancer, 2014.

Co-Morbidities in Elderly Breast Cancer Patients Treated with Chemotherapy. Romina Sosa, Julia Molony, Shuling Li, Richard Barron, Phuong Khanh Morrow, Scott Stryker, Jiannong Liu, Allan J. Collins, John Acquavella. Oral Presentation at the Multinational Association of Supportive Care in Cancer, 2014.

Mortality among Women Diagnosed with Stage II or III Breast Cancer Based on SEER-Medicare Data. Rohini K. Hernandez, Alexander Liede, Shuling Li, Jiannong Liu, Yan Hu, Scott Stryker, Anne H. Blaes, Allan J. Collins. Oral presentation at the American Society of Clinical Oncology Breast Cancer Symposium, 2014.

Prevalence of Nonmetastatic Prostate Cancer Patients on Continuous Androgen Deprivation Therapy in the United States. Karynsa Cetin, Shuling Li, Anne H. Blaes, Scott Stryker, Alexander Liede, Thomas J. Arneson. Presented at the American Society of Clinical Oncology Annual Meeting, 2012.

Patterns of Granulocyte Colony Stimulating Factor (G-CSF) Use in Elderly Breast Cancer Patients Receiving Myelosuppressive Chemotherapy. Anne Blaes, John Page, Craig Solid, Victoria Chia, Mi Rim Choi, Rich Barron, Tom Arneson. Presented at the San Antonio Breast Cancer Symposium, 2012.

Prevalence of Recognized Bone Metastases in the US Adult Population. Shuling Li, Yi Peng, Eric D. Weinhandl, Anne H. Blaes AH, Karynsa Cetin, Victoria M. Chia, Scott Stryker, Joseph J. Pinzone, John F. Acquavella, Thomas J. Arneson. Presented at the American Society of Clinical Oncology Annual Meeting, 2011.

Impact of Medicare’s July 2007 Erythropoiesis Stimulating Agent (ESA) National Coverage Determination (NCD) on Transfusion Use in Chemotherapy-Treated Cancer Patients. Thomas J. Arneson, Shuling Li, David T. Gilbertson, Stephan C. Dunning, Kenneth R. Bridges, John F. Acquavella. Presented at the American Society of Clinical Oncology Annual Meeting, 2010.

Publications

View papers published under the Scientific Registry of Transplant Recipients (SRTR).

Wang JH, Skeans MA, Israni AK. Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis. 2016;23:281-286.

Israni AK, Snyder JJ, Skeans MA, Kasiske BL. Clinical Diagnosis of metabolic syndrome: predicting new onset diabetes, coronary heart disease, and allograft failure late after kidney transplant. Transpl Int. 2012;25:748-757.

Ibrahim HN, Ishani A, Snyder JJ, Skeans M, Li Q. Blood transfusions in kidney transplant candidates are common and associated with adverse outcomes. Clin Transpant. 2011;25: 653-659.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis. 2011;57:466-475.

Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qui Y, Peng Y, Dharnidharka VR, Israni AK. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis. 2011;58:971-980.

Pilmore HL, Skeans MA, Snyder JJ, Israni AK, Kasiske BL, for the PORT Investigators. Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation (PORT) study. Transplantation. 2011;91:542-551.

Israni AK, Snyder JJ, Skeans MA, Peng Y, Weinhandl ED, Kasiske, BL, for the PORT Investigators. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010;10:338-353.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA, Peng Y, Weinhandl ED. A simple tool to predict outcomes after kidney transplant. Am J Kidney Dis. 2010;56:947-960.

Israni AK, Snyder JJ, Skeans MA, Tuomari AV, Maclean JR, Kasiske BL. Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol. 2009;30:430-439.

Snyder JJ, Israni A, Peng Y, Zhang L, Simon T, Kasiske B. Rates of first infection following kidney transplant in the United States. Kidney Int. 2009;75:317-326.

Posters & Presentations

Characterization and Waiting List Outcomes of Patients with CF Listed for Lung Transplantation. Lasair O’Callaghan, Julia Molony, Yi Peng, Ellison Suthoff, Jon Snyder, David Waltz. Presented at the North American Cystic Fibrosis Conference, 2016.

Incidence of Kidney Transplant in Daily Home Hemodialysis, Peritoneal Dialysis, and In-Center Hemodialysis Patients. Eric Weinhandl, Allan Collins. Presented at the National Kidney Foundation Spring Clinical Meeting, 2015.

Publications

Li S, Molony JT, Cetin K, Wasser JS, Altomare I. Rate of bleeding-rated episodes in elderly patients with primary immune thrombocytopenia: a population-based retrospective cohort study using Medicare 20% sample data. Curr Med Res Opin. 2018;34:209-216.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ. Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders. Pharmacoepidemiol Drug Saf. 2016;25:269-277.

Posters & Presentations

Rituximab Use in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Julia T. Molony, Anne Sexter, Karynsa Cetin, Ivy Altomare, Jeffrey Wasser. Presented at the Thrombosis & Hemostasis Societies of North America Biennial Summit, 2018.

Splenectomy in Elderly Patients Newly Diagnosed with Primary Immune Thrombocytopenia. Shuling Li, Anne Sexter, Julia T. Molony, Karynsa Cetin, Jeffrey Wasser, Ivy Altomare. Presented at the Thrombosis & Hemostasis Societies of North America Biennial Summit, 2018.

Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data. Shuling Li, Julia T. Molony, Karynsa Cetin, Jeffrey S. Wasser, Ivy Altomare. Oral presentation at the American Society of Hematology Annual Meeting, 2015.

Elevated Risk of End-Stage Renal Disease, Cardiovascular Events, and Infection Associated With Diabetic Kidney Disease. James B. Wetmore, Suying Li, Thanh G.N. Ton, Cheryl Neslusan, Michael K. Hansen, Ralph Riley, David T. Gilbertson. Presented at the American Diabetes Association Scientific Sessions, 2017.

New Policies, New Sources of Error: Impact of Recent Medicare Policies on Database Research. David T. Gilbertson, Jiannong Liu, Anne C. Beaubrun, Glenn M. Chertow, Kenneth J. Rothman, Wolfgang C. Winkelmayer, Keri L. Monda, Akhtar Ashfaq, M. Alan Brookhart, Allan J. Collins, Brian D. Bradbury. Presented at the International Society Pharmacoepidemiology Annual Conference, 2016.

Potential Effects of Medicare Payment Policy Changes on Hospitalization-Based Outcomes Research. Anne C. Beaubrun, David Gilbertson, Glenn Chertow, Kenneth Rothman, Wolfgang Winkelmayer, Keri Monda, Jiannong Liu, Akhtar Ashfaq, M. Alan Brookhart, Allan Collins, Brian Bradbury. Presented at the International Society Pharmacoepidemiology Annual Conference, 2016.

Association of Potassium with Mortality: Data from a Metropolitan Safety-Net Hospital. Charles A. Herzog, James B. Wetmore, Wendy L. St. Peter, David T. Gilbertson. Presented at the American Heart Association Scientific Sessions, 2016.

Contact Us

Chronic Disease Research Group

Hennepin Healthcare Research Institute

701 Park Ave.

Suite S2.100

Minneapolis, MN 55415

Email: cdrg@cdrg.org

Tel: 612.873.6200

Mon-Fri: 8:00 AM - 4:30 PM CT

The Chronic Disease Research Group (CDRG) is a division of the Hennepin Healthcare Research Institute (formerly known as the Minneapolis Medical Research Foundation), located in Minneapolis, MN